IC
GWPH

Inscription Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Inscription Capital’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-650
Closed -$63K – 297
2018
Q4 		$63K Buy
+650
New +$85.3K 0.04% 187

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Inscription Capital's GWPH Position: Q1 2019 in Review

Inscription Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 650 shares — an estimated $63K sold.

Inscription Capital first reported a position in GWPH in Q4 2018 and held it in 1 quarter. The position peaked at $63K in Q4 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

  • Inscription Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Inscription Capital sold 650 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $63K.
  • Inscription Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 1 quarter.
  • Inscription Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $63K in Q4 2018.
  • 320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Inscription Capital's 13F filing for Q1 2019, filed 16 May 2019.